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Background: Breast cancer is the leading cause of cancer deaths in women world-wide. In low and middle income
countries, where there are no population-based mammographic screening programmes, late presentation is common,
and because of inadequate access to optimal treatment, survival rates are poor. Mammographic screening is
well-studied in high-income countries in western populations, and because it has been shown to reduce
breast cancer mortality, it has become part of the healthcare systems in such countries. However the performance of
mammographic screening in a developing country is largely unknown.
This study aims to evaluate the performance of mammographic screening in Malaysia, a middle income country, and
to compare the stage and surgical treatment of screen-detected and symptomatic breast cancer.
Methods: A retrospective review of 2510 mammograms performed from Jan to Dec 2010 in a tertiary medical centre
is carried out. The three groups identified are the routine (opportunistic) screening group, the targeted (high risk)
screening group and the diagnostic group. The performance indicators of each group is calculated, and stage
at presentation and treatment between the screening and diagnostic group is analyzed.
Results: The cancer detection rate in the opportunistic screening group, targeted screening group, and the
symptomatic group is 0.5 %, 1.25 % and 26 % respectively. The proportion of ductal carcinoma in situ is 23.1 % in the
two screening groups compared to only 2.5 % in the diagnostic group. Among the opportunistic screening group,
the cancer detection rate was 0.2 % in women below 50 years old compared to 0.65 % in women 50 years and above.
The performance indicators are within international standards. Early-staged breast cancer (Stage 0–2) were 84.6 % in
the screening groups compared to 61.1 % in the diagnostic group.
Conclusion: From the results, in a setting with resource constraints, targeted screening of high risk individuals will give
a higher yield, and if more resources are available, population-based screening of women 50 and above is effective.
Opportunistic mammographic screening is feasible and effective in a middle income country with performance
indicators within international standards. Waiting until women are symptomatic will lead to more advanced cancers.
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No % No % No %
0 Incomplete 7 0.4 1 0.4 0
1 Negative 887 45.8 102 42.5 47 15.1
2 Benign findings 911 47 114 47.5 103 33.0
3 Probably benign
abnormality
93 4.8 11 4.6 49 15.7
4 Suspicious abnormality 35 1.8 11 4.6 51 16.3
5 Highly suggestive
of malignancy
5 0.2 1 0.4 62 19.9
Total 1938 100 240 100 312 100
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Breast cancer is the leading cause of cancer deaths in
women worldwide. The two main determinants of sur-
vival are early detection and optimal treatment. In low
and middle income countries (LMICs), late presentation
of breast cancer is common. While geographical isola-
tion and poverty may lead to delayed presentation, psy-
chosocial and cultural beliefs are also major barriers
[1]. The three methods of early detection are breast
self-examination (BSE), clinical breast examination (CBE)
and mammography. While BSE and CBE can lead to
downstaging of symptomatic disease, screening for asymp-
tomatic disease by mammography will allow for detec-
tion of breast cancer in the earliest stage where cure is
possible [2].
There is no population based mammographic screen-
ing programme in most LMICs including Malaysia, be-
cause such a programme would require not only the
facilities and manpower for the process of screening, but
also a robust and equitable healthcare system that can
provide for the diagnosis, treatment and follow-up of
women with abnormalities diagnosed on screening. How-
ever, in a country like Malaysia, which is in transition from
a developing to a developed country, women especially in
the urban areas in Malaysia, are becoming more educated
and with information gleaned from the media about the
increasing incidence of breast cancer, and the import-
ance of early detection, more women are coming for-
ward for screening mammography. University Malaya
Medical Centre (UMMC) is a public hospital in an urban
area in Malaysia, and since 1993, has a mammography ser-
vice which provides opportunistic and targeted mammo-
graphic screening, together with diagnostic mammograms
at request of doctors from the Breast Clinic, Primary
Medicine clinic as well as from the Gynaecology Clinic.
The objective of this study is to evaluate the perform-
ance of opportunistic screening mammography in a fully
equipped tertiary medical centre with a breast unit and to
compare the stage and treatment of screen-detected to
that of symptomatic breast cancers.
Methods
A retrospective study of 2510 consecutive full film digital
mammograms (FFDM) performed at the University
Malaya Medical Centre (UMMC), a tertiery teaching hos-
pital in an urban setting, from January to December 2010
were reviewed. This study was approved by the Ethical
Review Committee of UMMC. As is the current practice
in the breast imaging unit of the hospital, two views
(medio-lateral and cranio-caudal) are carried out and the
mammograms are reported immediately by trained breast
radiologists. Adjunct ultrasound is carried out at the same
time when deemed necessary, usually for dense breasts or
for further evaluation of any mammographic abnormality.The reason for the mammogram is stated in the mammo-
gram request form, and this information is available to
the radiologist. 2178 mammograms were performed on
asymptomatic women while 332 (13.2 %) were diagnostic
mammograms. In the former group, 1938 (77.2 %) were
routine screening mammograms (defined as 40 years and
above with an average risk for developing breast cancer),
while 240 (9.6 %) were targeted mammographic screening
in a group of women at higher risk for developing breast
cancer (defined as a positive family history, previous bi-
opsy showing atypical ductal hyperplasia, or on hormone
replacement therapy). In the diagnostic group, 20 had
already had a biopsy showing a malignancy before mam-
mography was carried out, and these were excluded; leav-
ing 312 for analysis. The ages of the women, Breast
Imaging Reporting and Data System (BI-RADS) assess-
ment category (Table 1) [3], breast density composition,
adjunct ultrasound, type of biopsy and histopathological
results were retrieved from the computerized imaging sys-
tem, imaging reports and hospital records. The data was
analyzed using SPSS Statistics Version 22. The stage of
the cancer and surgical treatment in the screening groups
were compared with the diagnostic group. The rou-
tine screening group (1938 women) was used as a surro-
gate for the opportunistic screening group and separately
analyzed.
Results
In the targeted screening group, 219 had a family history
of breast cancer (65 % were in first degree relatives), 13
were on hormone replacement therapy, while 8 had a
previous excision biopsy showing atypical ductal hyper-
plasia. In the diagnostic group, the commonest symptom
was a breast lump, and the median duration of symp-
toms was 6 months. Table 1 shows the BI-RADS assess-
ment category in the three groups of women presenting
for mammography. In the screening groups, the majority
of women were classified as BIRADS 1 and 2 which do
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the mean age was similar in the three groups. The ma-
jority of patients were Chinese, which is consistent with
the higher incidence of breast cancer in the Chinese
population in Malaysia.
In the diagnostic group, 81 of the 312 women (26 %)
were confirmed to have invasive and non-invasive breast
cancer compared to only 10 out of 1938 (0.52 %) in the
opportunistic screening group. In the 240 women with an
elevated risk of breast cancer (family history and atypical
ductal hyperplasia), 3 cancers were found giving a pick-up
rate of 1.25 %.
It is interesting to note that in the diagnostic group,
there were only two women with ductal carcinoma-in-
situ (DCIS) compared to 79 with invasive cancer (DCIS
rate of 2.5 %). In the two screening groups, there were
three in-situ cancers compared to 10 invasive cancers
(DCIS rate of 23.1 %) The biopsy rate in the opportunistic
screening group was 2.3 %, while it was 5.4 % in the tar-
geted screening group. This is compared to the diagnostic
group which had a biopsy rate of 47.8 %. The positive pre-
dictive value (PPV) for biopsies was 22.7 % and 23 % in
the opportunistic screening group and targeted screening
group respectively. As expected, PPV for biopsies was very
high (54.3 %) in the diagnostic group. BI-RADS 4–5 is
classified as a suspicious examination with positive finding
which requires tissue diagnosis for confirmation, whereas
BI-RADS 3 category are “probably benign findings” which
require a close follow-up. In the two screening groups,











Cancer detection rate (invasive and in-situ) 0.52
Invasive carcinoma 8
DCIS 2 (20 %)
No of biopsies 44
Biopsy rate 2.3 %
PPV for abnormal mammogram (BIRADS 3–5) 7.5 %
PPV for suspicious mammogram (BIRADS 4–5) 25 %
PPV for biopsies 22.7 %report of BIRADS 4 (12.2 %) and 5 out of 7 BIRADS 5
(71.4 %) were malignant. The PPV for abnormal mammo-
gram (BI-RADS 3–5) was 7.5 % in the opportunistic
screening group and double that for the targeted screen-
ing group. PPV for abnormal mammogram in the diag-
nostic group was very high (63.2 %). When we consider
BI-RADS 4–5 as the positive group, the PPV increased to
25 % in both the opportunistic and targeted screening
groups, while it was 71.7 % in the diagnostic group.
When the stage at diagnosis in the screening groups
was compared with the diagnostic group, it was shown
that 84.6 % breast cancer diagnosed by screening was in
the early stages (Stage 0–2) compared to 61.1 % in the
diagnostic group. However, of those who had surgery,
76.9 % of the screening group had mastectomy com-
pared with 77.3 % in the diagnostic group, showing that
there was no difference in the mastectomy rate, whether
screen detected or detected with symptoms (Table 3).
The effect of age on performance in the opportunistic
screening group was separately analyzed (Table 4) in this
group, 25 % were less than 50 years old. As expected,
breast density was significantly higher (p = 0.00) in the <
50 age group (22.5 % dense and 66.3 % moderately
dense) compared to the 50 and above age group (12.4 %
dense and 60.5 % moderately dense). Supplementary
ultrasound was done in 31.7 % of women undergoing
routine mammography and it was more likely to be car-
ried out in the <50 age group (p = 0.01) The cancer de-
tection rate was only 0.2 % in women < 50 years old
compared to 0.62 % in women 50 and above. The biopsyic mammogram
Diagnostic
mammogramammogram Targeted screening mammogram
No % No %
56.4 54.2
130 54.2 121 38.8
63 26.3 71 22.8
43 17.9 115 36.9
4 1.7 5 1.6
240 100 312 100
1.25 26.0 %
2 79
1 (33.3 %) 2 (2.5 %)
13 149
5.4 % 47.8 %
13 % 63.4 %
25 % 71.7 %
23 % 54.3 %









0 3 (23.0 %) 2 (2.6 %) 0.00*
1 4 (30.8 %) 18 (23.4 %)
2 4 (30.8 %) 27 (35.1 %)
3 2 (15.4 %) 14 (18.2 %)
4 16 (20.7 %)
Unstaged 0 4
Type of Surgery
Mastectomy 10 (76.9 %) 51 (77.3 %) 0.97
Breast conserving
surgery
3 (23.1 %) 15 (22.7 %)
No surgery done 0 15
*Significant
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the positive predictive value (PPV) for biopsies were sig-
nificantly higher in the 50 years and above age group.
Discussion
A meta-analysis of 11 randomized controlled trials (RCTs)
on mammographic breast screening showed a 20 % reduc-
tion in breast cancer mortality in women invited for
screening with 13 years of follow-up, particularly in the
50–69 year age group [4]. However the question of overdi-
agnosis and overtreatment has been debated in recent
years, and it has been recommended that women should
be fully informed about the harms and benefits before they
decide whether to screen or not [5]. In Asian countries,
there have been no RCTs on population-based mammo-
graphic screening, except for a pilot prevalence screening
programme in Singapore [6]. The performance of op-
portunistic screening programmes have been reportedTable 4 Effect of age on performance of opportunistic mammogram
Less than 50 years old
Number 484 (25 %)
Cancer detection rate 0.20 %
Dense breasts 22.5 %
Moderately dense breasts 66.3 %
Adjunct ultrasound done 42.7 %
BIRADS 3–5 (abnormal mammogram) 40 (8.2 %)
BIRADS 4–5 (suspicious mammogram) 10 (2.1 %)
Biopsy rate 3.7 %
PPV for abnormal mammogram 2.5 %
PPV for suspicious mammogram 10 %
PPV for biopsies 5.5 %
*Significantin Japan [7] and Hong Kong [8]. However these are high
income countries in Asia. Very little data on opportunistic
mammographic screening is available in LMICs in Asia.
Population-based cancer screening is distinguished from
opportunistic screening on the basis of how invitations to
screening are extended. Population-based screening is is-
sued from population-based registers, while opportunistic
screening depends on an asymptomatic individual’s per-
sonal decision whether to screen or not, or based on advice
from an encounter with a health professional. Population-
based programs focus on reducing mortality and morbid-
ity from breast cancer at the level of the population, while
opportunistic screening may not have all the hallmarks of
a population-based program, namely, eligibility require-
ments, quality assurance, follow-up and evaluation [9]. A
study in Switzerland showed that population-based mam-
mographic screening was as effective as opportunistic
screening [10] while another study in Denmark showed
that population-based screening had considerably higher
sensitivity than opportunistic screening, while the specifi-
city was similar in the two settings [11].
Rigorous, high quality screening, diagnosis and treatment
are crucial in attaining the goal of reducing breast cancer
mortality rates through screening. The programme needs
to be audited to ensure that performance indicators are
met [12]. Unfortunately not all the elements required for a
population-based mammographic screening programme,
namely manpower, quality assurance and optimal access to
treatment, are available in low and middle income coun-
tries. In such countries, several opportunistic programmes
are available through hospitals, with several funded by
non-governmental organizations. However most of these
programmes are not evaluated. This study in a tertiary
hospital has the elements required for a high-quality
programme, with a multidisciplinary breast team in place
since 1993.screening
50 years and above All age groups P value
1454 (75 %) 1938
0.62 % 0.52 % 0.2
12.4 % 15 % 0.00*
60.5 % 62.4 %
28.1 % 31.7 % 0.00*
93 (6.3 %) 133 (6.8 %) 0.2
30 (2.1 %) 40 (2.1 %)
1.8 % 2.3 % 0.028*
9.6 % 7.5 % 0.1
30 % 25 % 0.2
34.6 % 22.7 % 0.01*
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location of UMMC in an urban mainly Chinese neigh-
bourhood. The mean age of 55.6 years was typical of the
age group eligible for mammographic screening which is
between 40 and 70. Because the most prevalent age group
for breast cancer in Malaysia is 40–49 years old [13], this
age group is offered mammographic screening if they wish
to do so, and comprises 25 % of opportunistic mammo-
graphic screening group. The cancer detection rate in this
group was 0.5 %, which is consistent with what was re-
ported in opportunistic screening programmes in Japan
and Hong Kong [7, 8], where the age standardized inci-
dence rate of breast cancer is similar. The pilot population
based mammographic screening programme in Singapore
reported a cancer detection rate of 0.48 % [6]. As expected
the cancer detection rate was lower than that reported in
high incidence countries like USA and UK at first mam-
mogram screening (0.8 and 1.0 % respectively) [14].
In the group of women with a risk factor, such as family
history, hormone replacement therapy, and atypical ductal
hyperplasia (targeted screening) the cancer detection rate
was more than doubled (1.25 %), as expected, as their risk
of developing breast cancer is higher.
What is striking in the two screening groups is that
the proportion of DCIS (ductal carcinoma in situ) was
23.1 %, compared to only 2.5 % in the diagnostic group.
The DCIS rate in the study in Singapore was 26 % [6],
30 % in Japan [7] and 28 % in Hong Kong [8]. In contrast
the DCIS rates in high-incidence countries like UK and
USA are much lower (8.3 % and 12.3 %) [14]. The propor-
tion of DCIS in this study is also well above the minimum
standard of 10 % set by the IARC [12]. The higher rate of
screen detected DCIS in Asians have also been noted in
other studies, and is postulated to be due to a different
pattern of growth in Asian women [15].
31.5 % of women undergoing routine mammography
screening had ultrasound done, especially in women below
50 years old. In an opportunistic setting as practiced by
UMMC, mammograms are immediately read and any fur-
ther imaging is carried out at the same visit. It is also
noted that Asian women, especially of Chinese ethnicity,
have denser breasts [16] and supplementary ultrasound in
such cases would be able to identify any abnormalities
missed on mammography alone [17]. 77.4 % of women
had dense or moderately dense breasts in this study and
mammography density was higher in younger women. In
population-based screening, the mammogram is reported
later and if any additional imaging is to be carried out, the
woman is recalled for further tests. The percentage of re-
call should be less than 7 % according to the performance
indicators set up by IARC [12], hence a supplementary
ultrasound of 31.5 % appears excessive, but opportunistic
screening is very much at the individual level rather than
at the population level.For a screening programme to be cost-effective, recall
rates and biopsy rates should be low, and PPV should be
high. The PPV of an abnormal mammogram in the op-
portunistic screening arm of this study was 7.5 %, biopsy
rate was 2.3 %, and the PPV for biopsies was 22.7 %. This
is acceptable by international standards [18] and similar to
the reported rates in Japan [7] and Hong Kong [8]. Biopsy
rates are higher in the targeted screening group, which
also has a higher PPV for biopsies and for abnormal
mammograms.
Although the stage of the cancer in the screening arms
was significantly earlier compared to the stage in the
diagnostic arm (84.6 % Stage 0–2 compared with 61.1 %,
p = 0.00), the mastectomy rates between the screening
and diagnostic groups were not different. It has been re-
ported that Asian patients are more likely to choose
mastectomy for a variety of reasons, the most important
of which is that they feel safer, and also because they do
not want radiotherapy [19]. It is also interesting to note
that in the diagnostic group, 4 women (4.9 %) defaulted
any further management and were not staged, while 15
women in the diagnostic group did not have any surgery
carried out, either because they refused or were meta-
static at diagnosis. Delayed presentation and defaulting
treatment has been described in LMICs [1, 20].
The cancer detection rate was lower in the age group
below 50 years old (0.2 %) compared with the 50 years
and above age group (0.62 %). This differs from the op-
portunistic screening programme in Japan and Hong
Kong where cancer detection rates were higher in women
less than 50 years old [7, 8] but similar to a study in USA
where cancer detection rates were higher in the older age
group [21]. Since the prevalent age group for breast cancer
in Malaysia is the 40–49 year age group, it is difficult to
understand the lower cancer detection rate in the younger
women; however it could be that there were false nega-
tives in this group since the breasts are dense and cancers
may be missed. While the biopsy rate in women below
50 years is higher, the PPV for positive biopsies was much
lower in this age group.
The limitation of this study is that it is a single snapshot
of the mammography service in UMMC over a one-year
period, and the false negative rate and interval cancer rate
is unknown. However the opportunistic screening mammo-
gram group can be a surrogate of whether a population-
based programme is feasible but only if the similar facilities
are available. Depending on the resources available, a tar-
geted screening programme (for women with increased
risk) with its higher cancer detection rate should be car-
ried out initially and once resources become more avail-
able, routine screening for women 50 years and above. In
Malaysia, it is not likely to be cost-effective to routinely
screen women below the age of 50 years, because of the
low cancer detection rate, high biopsy rate, and the PPV
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it is noted that the current policy by the Ministry of
Health in Malaysia to offer free mammographic screening
to women who are at higher risk of breast cancer based
on known risk factors may miss a significant number of
cancers as 10 out of the 13 cancers found (76.9 %) were
from women with no risk factors.
Conclusions
Based on this study, the performance of mammographic
screening is within acceptable international standards.
Screening a high risk group would give the best cancer de-
tection rate, with acceptable biopsy rate, PPV for abnormal
mammogram and biopsies. With more resources, screen-
ing can be extended to all women 50 years and above, as
the cancer detection rate and acceptable performance in-
dicators make it feasible. Waiting for women to become
symptomatic will lead more advanced cancers, which will
require more resources for treatment.
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